Amylyx Pharmaceuticals (AMLX)
(Delayed Data from NSDQ)
$1.99 USD
-0.04 (-1.97%)
Updated May 6, 2024 04:00 PM ET
After-Market: $1.98 -0.01 (-0.50%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: BMO |
3/2024 | $0.24 | 0.00% |
Earnings Summary
For their last quarter, Amylyx Pharmaceuticals (AMLX) reported earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.20 per share. This reflects a negative earnings surprise of 65.00%. Look out for AMLX's next earnings release on May 09, 2024. For the next earning release, we expect the company to report earnings of $0.24 per share, reflecting a year-over-year increase of 1100%.
Earnings History
Price & Consensus
Zacks News for AMLX
Biotech Stock Roundup: MRNA Up on Vaccine Data, BMY's Updates & More News
AMLX: What are Zacks experts saying now?
Zacks Private Portfolio Services